胃内球囊市场 - 全球产业规模、份额、趋势、机会及预测（按给药方式、球囊类型、充盈类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球胃内球囊市场预计将从 2025 年的 8,627 万美元成长到 2031 年的 1.7885 亿美元，复合年增长率为 12.92%。

这些临时性的微创装置透过占据胃部空间来诱导早期饱腹感，有效弥合了保守的生活方式调整和侵入性减肥手术之间的关键治疗缺口。这一市场成长的根本驱动力是日益严重的全球肥胖问题，亟需可扩展的治疗方案。例如，世界肥胖联盟在2024年预测，到2035年，全球肥胖成年人数将达到15.3亿，这将持续催生对风险低于永久性手术的非手术体重管理方案的需求。

然而，儘管市场需求明确，但器械安全性和潜在不利事件仍构成市场扩张的重大障碍。包括自发性球囊过度充气、急性胰臟炎和胃穿孔在内的併发症报告，导致监管机构加强审查并发布安全警告，降低了患者的信心和接受度。此外，高昂的手术费用以及保险公司报销不均或报销额度有限等经济障碍，进一步限制了市场准入，导致相当一部分合格的患者无法获得这些治疗。

市场驱动因素

推动胃内球囊市场发展的主要因素是全球肥胖和超重人口的成长，这迫切需要有效的干预措施来弥合生活方式改变和侵入性手术之间的差距。随着全球体重指数（BMI）水平的上升，医疗保健系统正转向扩充性的、基于器械的治疗方法，以减轻肥胖相关併发症的负担。近期监测数据凸显了这项人口压力。 KGOU 2025年12月的一份报告引述美国疾病管制与预防中心（CDC）的数据指出，到2024年，美国所有州和地区至少四分之一的成年人将患有肥胖症。这凸显了公共卫生危机的严重性以及由此产生的对非手术治疗方案的需求。

此外，诸如可吞嚥可调节球囊设计等技术创新，解决了患者对传统内视镜插入风险和侵入性的担忧，正在推动市场成长。新一代基于平板电脑的给药系统实现了非手术部署，提高了患者依从性，并将市场拓展至寻求可逆、低风险治疗方案的患者群体。这些进步的商业性成功显而易见：2025年6月，Allurion Technologies报告称，其B2B2C销售模式在欧洲实现了超过40%的成长，显示消费者需求强劲。此外，Allurion在2025年3月宣布2024财年全年营收达3,210万美元，巩固了该行业的财务永续性，并表明这些技术的普及应用日益广泛。

市场挑战

全球胃内球囊市场成长的主要障碍在于人们对该器械安全性和不利事件的持续担忧。儘管这些器械的设计理念是微创，但诸如自发性过度充气、急性胰臟炎和胃穿孔等严重併发症的发生，导致监管机构加强审查、发布安全警告并强制召回产品。这些问题直接削弱了患者的信心，并导致医疗服务提供者不愿意推荐这种疗法。因此，对于相当一部分合格的患者而言，潜在临床风险的担忧超过了其预期获益，从而导致犹豫不决和市场渗透率有限。

这些安全隐患的实际影响体现在手术量的急剧下降。美国代谢与减重外科协会 (ASMBS) 预计，2023 年美国胃内球囊手术的数量将降至 1461 例，较前一年的 4358 例大幅下降。这一显着下降表明，安全隐患以及由此产生的临床谨慎态度正在有效地抑制市场成长，并阻碍该技术达到能够满足日益增长的非手术减重治疗需求的规模。

市场趋势

人工智慧驱动的数位健康生态系统的整合正在重塑胃内球囊市场，并将产业重点转向综合护理模式。製造商正日益将设备与演算法指导平台结合，以追踪即时生理指标，从而提高患者安全性和治疗依从性。这个数位化层面支持个人化干预，有助于实现重要的临床结果，例如在减重过程中保持肌肉量。 Allurion Technologies 在新闻稿中强调了这种方法的价值，该新闻稿引用了该公司在 2025 年 5 月欧洲肥胖研究学会会议上公布的数据。该公司报告称，使用其人工智慧虚拟护理套件的患者在四个月内平均瘦体重增加了 6.1%，证明了数位辅助性治疗的有效性。

同时，一种全新的高效治疗模式正在兴起：胃内球囊合併GLP-1受体促效剂的联合治疗。透过利用球囊的机械饱足感，临床医生可以减少药物剂量，最大限度地降低减重，并改善体重减轻效果。这种协同疗法能够最大限度地减少脂肪，并克服单一疗法的局限性，例如减重停滞期。 Alurion Technologies公司于2025年11月公布的数据支持了此策略的有效性。接受该公司智慧胶囊联合治疗低剂量替拉唑肽治疗的患者，在12个月后平均体重减轻了23%，显着优于以往仅使用器械治疗的效果。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球胃内球囊市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依给药途径（片剂与内视镜）
  • 依气球类型（单层、双层、三层）
  • 依充注类型（生理食盐水充注与气体充填）
  • 依用途（肥胖、糖尿病、饮食管理等）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美胃内球囊市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲胃内球囊市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区胃内球囊市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲胃内球囊市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲胃内球囊市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球胃内球囊市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Apollo Endosurgery, Inc.
• Allurion Technologies, Inc.
• Obalon Therapeutics, Inc.
• Medtronic plc
• GI Dynamics, Inc.
• Spatz Medical, Inc.
• Lexel Medical, Inc.
• Bariatric Solutions, Inc.
• Endogastric Solutions, Inc.
• Reshape Lifesciences, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Intragastric Balloons Market is projected to expand from USD 86.27 Million in 2025 to USD 178.85 Million by 2031, registering a CAGR of 12.92%. These temporary, minimally invasive devices function by occupying gastric space to induce early satiety, effectively addressing the critical treatment gap between conservative lifestyle adjustments and invasive bariatric surgeries. This market growth is fundamentally driven by the escalating global burden of obesity, which demands scalable therapeutic solutions. For instance, the World Obesity Federation projected in 2024 that the number of adults living with obesity worldwide would rise to 1.53 billion by 2035, creating sustained demand for non-surgical weight management options with a more favorable risk profile than permanent surgical procedures.

However, despite the clear demand, market expansion faces significant hurdles regarding device safety and potential adverse events. Reports of complications, such as spontaneous balloon hyperinflation, acute pancreatitis, and gastric perforation, have triggered increased regulatory scrutiny and safety alerts that diminish patient confidence and adoption rates. Additionally, financial barriers further restrict market access, as high procedural costs are often compounded by inconsistent or limited reimbursement coverage from insurance payers, preventing a substantial portion of the eligible patient population from accessing these treatments.

Market Driver

The primary catalyst propelling the intragastric balloons market is the rising global prevalence of obesity and overweight populations, which necessitates effective interventions to bridge the divide between lifestyle modifications and invasive surgeries. As body mass index levels increase globally, healthcare systems are turning to scalable, device-based therapies to alleviate the burden of obesity-related comorbidities. This demographic pressure is highlighted by recent surveillance data; a December 2025 report by KGOU citing Centers for Disease Control and Prevention data revealed that in 2024, at least one in four adults across all U.S. states and territories lived with obesity, underscoring the severity of this public health crisis and the resulting demand for non-surgical therapeutic alternatives.

Market growth is further accelerated by technological innovations in swallowable and adjustable balloon designs, which address patient apprehensions regarding the risks and invasiveness of traditional endoscopic placement. Next-generation, pill-based delivery systems enable procedure-less deployment, thereby enhancing patient compliance and broadening the market to those seeking reversible, lower-risk options. The commercial success of these advancements is evident; Allurion Technologies reported in June 2025 that its B2B2C sales model achieved over 40% growth in Europe, indicating strong consumer uptake. Furthermore, the segment's financial viability was reinforced when Allurion announced a full-year 2024 revenue of $32.1 million in March 2025, demonstrating the increasing utilization of these technologies.

Market Challenge

A major impediment to the growth of the global intragastric balloons market is the persistent concern surrounding device safety and adverse events. While these devices are designed to be minimally invasive, incidents of serious complications-including spontaneous hyperinflation, acute pancreatitis, and gastric perforation-have led to intensified regulatory scrutiny, safety alerts, and mandatory product recalls. These issues directly undermine patient confidence and deter healthcare providers from recommending the therapy. Consequently, for a significant segment of eligible patients, the fear of potential clinical risks often outweighs the perceived benefits, resulting in hesitancy and limited market penetration.

The tangible impact of these safety challenges is evident in the sharp contraction of procedural volumes. According to the American Society for Metabolic and Bariatric Surgery, the estimated number of intragastric balloon procedures in the United States fell to 1,461 in 2023, a significant decline from the 4,358 procedures recorded the prior year. This substantial decrease illustrates how safety-related apprehensions and the resulting caution within clinical practice are effectively stifling market growth, preventing the technology from reaching the scale needed to meet the escalating demand for non-surgical weight loss interventions.

Market Trends

The intragastric balloons market is being reshaped by the integration of AI-driven digital health ecosystems, shifting the industry focus toward comprehensive care models. Manufacturers are increasingly pairing devices with algorithmic coaching platforms that track real-time physiological metrics to improve patient safety and adherence. This digital layer facilitates personalized interventions that support essential clinical outcomes, such as muscle preservation during weight loss. The value of this approach was highlighted by Allurion Technologies in May 2025; in a press release regarding data presented at the European Congress on Obesity, the company reported that patients using its AI-powered Virtual Care Suite achieved an average lean body mass increase of 6.1% over four months, validating the efficacy of digital adjuncts.

Concurrently, a new high-efficacy treatment paradigm is emerging through combination therapies that pair intragastric balloons with GLP-1 receptor agonists. By utilizing the balloon's mechanical satiety, clinicians can prescribe lower pharmaceutical dosages to minimize side effects while enhancing overall weight loss. This synergistic approach maximizes fat reduction and overcomes the limitations of standalone pharmacotherapy, such as weight loss plateaus. The potency of this strategy was underscored in November 2025, when Allurion Technologies released data showing that patients on a regimen of its Smart Capsule and low-dose tirzepatide achieved an average total body weight loss of 23% after 12 months, a result significantly surpassing historical outcomes for device-only interventions.

Key Market Players

• Apollo Endosurgery, Inc.
• Allurion Technologies, Inc.
• Obalon Therapeutics, Inc.
• Medtronic plc
• GI Dynamics, Inc.
• Spatz Medical, Inc.
• Lexel Medical, Inc.
• Bariatric Solutions, Inc.
• Endogastric Solutions, Inc.
• Reshape Lifesciences, Inc.

Report Scope

In this report, the Global Intragastric Balloons Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intragastric Balloons Market, By Administration

• Pill Form v/s Endoscopy

Intragastric Balloons Market, By Balloon Type

• Single
• Dual
• Triple

Intragastric Balloons Market, By Filling Type

• Saline Filled v/s Gas Filled

Intragastric Balloons Market, By Application

• Obesity
• Diabetes
• Diet Control
• Others

Intragastric Balloons Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Intragastric Balloons Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intragastric Balloons Market.

Available Customizations:

Global Intragastric Balloons Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intragastric Balloons Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Administration (Pill Form v/s Endoscopy)
  • 5.2.2. By Balloon Type (Single, Dual, Triple)
  • 5.2.3. By Filling Type (Saline Filled v/s Gas Filled)
  • 5.2.4. By Application (Obesity, Diabetes, Diet Control, Others)
  • 5.2.5. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Intragastric Balloons Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Administration
  • 6.2.2. By Balloon Type
  • 6.2.3. By Filling Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intragastric Balloons Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Administration
      • 6.3.1.2.2. By Balloon Type
      • 6.3.1.2.3. By Filling Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Intragastric Balloons Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Administration
      • 6.3.2.2.2. By Balloon Type
      • 6.3.2.2.3. By Filling Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Intragastric Balloons Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Administration
      • 6.3.3.2.2. By Balloon Type
      • 6.3.3.2.3. By Filling Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Intragastric Balloons Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Administration
  • 7.2.2. By Balloon Type
  • 7.2.3. By Filling Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intragastric Balloons Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Administration
      • 7.3.1.2.2. By Balloon Type
      • 7.3.1.2.3. By Filling Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Intragastric Balloons Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Administration
      • 7.3.2.2.2. By Balloon Type
      • 7.3.2.2.3. By Filling Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Intragastric Balloons Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Administration
      • 7.3.3.2.2. By Balloon Type
      • 7.3.3.2.3. By Filling Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Intragastric Balloons Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Administration
      • 7.3.4.2.2. By Balloon Type
      • 7.3.4.2.3. By Filling Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Intragastric Balloons Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Administration
      • 7.3.5.2.2. By Balloon Type
      • 7.3.5.2.3. By Filling Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Intragastric Balloons Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Administration
  • 8.2.2. By Balloon Type
  • 8.2.3. By Filling Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intragastric Balloons Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Administration
      • 8.3.1.2.2. By Balloon Type
      • 8.3.1.2.3. By Filling Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Intragastric Balloons Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Administration
      • 8.3.2.2.2. By Balloon Type
      • 8.3.2.2.3. By Filling Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Intragastric Balloons Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Administration
      • 8.3.3.2.2. By Balloon Type
      • 8.3.3.2.3. By Filling Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Intragastric Balloons Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Administration
      • 8.3.4.2.2. By Balloon Type
      • 8.3.4.2.3. By Filling Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Intragastric Balloons Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Administration
      • 8.3.5.2.2. By Balloon Type
      • 8.3.5.2.3. By Filling Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Intragastric Balloons Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Administration
  • 9.2.2. By Balloon Type
  • 9.2.3. By Filling Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intragastric Balloons Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Administration
      • 9.3.1.2.2. By Balloon Type
      • 9.3.1.2.3. By Filling Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Intragastric Balloons Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Administration
      • 9.3.2.2.2. By Balloon Type
      • 9.3.2.2.3. By Filling Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Intragastric Balloons Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Administration
      • 9.3.3.2.2. By Balloon Type
      • 9.3.3.2.3. By Filling Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Intragastric Balloons Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Administration
  • 10.2.2. By Balloon Type
  • 10.2.3. By Filling Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intragastric Balloons Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Administration
      • 10.3.1.2.2. By Balloon Type
      • 10.3.1.2.3. By Filling Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Intragastric Balloons Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Administration
      • 10.3.2.2.2. By Balloon Type
      • 10.3.2.2.3. By Filling Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Intragastric Balloons Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Administration
      • 10.3.3.2.2. By Balloon Type
      • 10.3.3.2.3. By Filling Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intragastric Balloons Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Apollo Endosurgery, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Allurion Technologies, Inc.
• 15.3. Obalon Therapeutics, Inc.
• 15.4. Medtronic plc
• 15.5. GI Dynamics, Inc.
• 15.6. Spatz Medical, Inc.
• 15.7. Lexel Medical, Inc.
• 15.8. Bariatric Solutions, Inc.
• 15.9. Endogastric Solutions, Inc.
• 15.10. Reshape Lifesciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer